Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?

Selma J. LekkerkerkerDepartment of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

Marc G. BesselinkDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands;

Olivier R. BuschDepartment of Surgery, Academic Medical Center, Amsterdam, The Netherlands;

Frederike DijkDepartment of Pathology, Academic Medical Center, Amsterdam, The Netherlands;

Marc R. EngelbrechtDepartment of Radiology, Academic Medical Center, Amsterdam, The Netherlands

Erik A. RauwsDepartment of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

Paul FockensDepartment of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

Jeanin E. van HooftDepartment of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Correspondence[email protected]

show all

Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date